Shire's Gaucher drug gets fast-track status in Europe

11/24/2009 | Reuters

The European Medicines Agency granted fast-track designation to Shire's velaglucerase alfa, a drug candidate for Gaucher disease. The company submitted the drug, which could address a shortage of Genzyme's Cerezyme, to the FDA in September.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC